Test Price
600 AED✅ Home Collection Available
Coxsackie Antibodies IgG & IgM Panel Test in UAE | 600 AED | DHA Licensed Lab
Executive Summary & Core Metrics
Executive Summary: The Coxsackie Antibodies IgG & IgM Panel is a dual-serum ELISA assay that detects past (IgG) and recent or active (IgM) immune responses to enteroviral infections, including hand-foot-mouth disease, myocarditis, and viral meningitis. Priced at 600 AED with a same-day report when the sample is received by 9 am Monday through Friday. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM across Dubai and select UAE emirates. Post-test telephonic clinical guidance is provided by a DHA-licensed general practitioner. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731. This panel delivers 99.9% diagnostic sensitivity through ISO 9001:2015 accredited ELISA processing at DNA Labs UAE.
Test Overview & Methodology
Clinical Role of Coxsackie Antibody Profiling
Coxsackieviruses belong to the Enterovirus genus and are classified into groups A and B. Group A serotypes predominantly cause hand-foot-mouth disease and herpangina, while group B serotypes are associated with myocarditis, pericarditis, pleurodynia, and aseptic meningitis. The IgG/IgM panel provides a serological snapshot: IgM antibodies indicate recent or active infection (typically detectable 3–7 days post-symptom onset and persisting for 8–12 weeks), while IgG antibodies denote past exposure and long-term humoral immunity. Combined interpretation aids UAE clinicians in differentiating acute enteroviral syndromes from prior immunity, guiding the need for further cardiac or neurological evaluation.
Methodology: Enzyme-Linked Immunosorbent Assay (ELISA)
The panel uses a solid-phase indirect ELISA format. Recombinant Coxsackie viral antigens (pooled serotypes A and B) are coated onto microtiter wells. Patient serum is incubated, and bound IgG or IgM antibodies are detected using enzyme-conjugated anti-human immunoglobulin antibodies. Colorimetric measurement at 450 nm provides quantitative optical density values, which are interpreted against manufacturer-derived cut-off thresholds. This method offers high specificity (>98%) and sensitivity (>99%) for both immunoglobulin classes from a single serum specimen.
| Feature | Our Coxsackie IgG/IgM Panel | Alternative Individual IgG or IgM Test |
|---|---|---|
| Precision & Method | ISO 9001:2015 ELISA, dual-parameter IgG+IgM simultaneously from one serum sample | Single-parameter ELISA for either IgG or IgM; may require separate blood draws |
| Turnaround Time | Same-day report when sample arrives by 9 am Monday–Friday | Next-day or 48-hour reporting |
| Clinical Guidance | Telephonic post-test interpretation with a DHA-licensed general practitioner | No integrated clinical follow-up |
| Home Collection | VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM–11 PM) | Clinic-only blood draw, no home service |
Physician Insight & Safety Protocols
Dr. Ajay Singh — General Practitioner | DHA Registration ID: 36234132
“Coxsackie antibody serology must be interpreted in the full clinical context: symptom trajectory, exposure history, cardiac and neurological signs, and basic lab markers such as troponin or CRP. A positive IgM with compatible acute illness strongly supports recent Coxsackie infection, whereas isolated IgG without IgM typically indicates past immunity. Clinicians should correlate these results with PCR testing and echocardiography when myocarditis is suspected. No serology result alone should delay emergency evaluation for chest pain, syncope, or severe headache.”
⚠️ Medication Advisory
Do not stop, adjust, or initiate any prescription medication based on panel results without direct consultation with your treating physician. This serological test is a diagnostic adjunct and does not replace emergency medical assessment for acute symptoms such as chest tightness, palpitations, breathing difficulty, or new-onset severe headache.
Exclusion Criteria & Emergency Red Flags
- Acute cardiac emergency: Patients with suspected myocarditis, ongoing chest pain, arrhythmia, or hemodynamic instability should seek immediate emergency care rather than outpatient phlebotomy.
- Severe bleeding risk: Individuals with known severe thrombocytopenia (platelets <30,000/µL), hemophilia, or anticoagulant therapy producing INR >3.5 must have venipuncture evaluated by the supervising physician first.
- Neurological urgency: New-onset seizure, altered consciousness, or focal neurological deficit warrants emergency neuroimaging before serological workup.
- Not for self-diagnosis: This panel requires a valid healthcare provider order and is intended for post-test clinical correlation only.
Patient FAQ & Clinical Guidance
1. What does a positive Coxsackie IgG with negative IgM indicate for my health?
A positive IgG result combined with a negative IgM points to past exposure to one or more Coxsackie serotypes, with the immune system maintaining long-term IgG antibodies. This pattern indicates immunity rather than active infection, requires no acute treatment, and is commonly observed in adults who experienced mild or subclinical enteroviral illness during childhood. Your physician may correlate this with your vaccination history and travel exposure.
2. How quickly can I receive my Coxsackie antibody panel results with home collection in Dubai?
Our VIP Mobile Phlebotomy service operates daily from 8 AM to 11 PM. When the blood sample reaches DNA Labs UAE by 9 AM on a weekday (Sunday through Thursday), the IgG/IgM panel is processed and a comprehensive digital report is released the same day. Samples arriving after 9 AM or on weekends are reported by the next working day. Results are delivered via secure patient portal and WhatsApp.
3. Can this serology panel distinguish hand-foot-mouth disease from Coxsackie myocarditis?
No single serology panel can definitively differentiate between clinical syndromes caused by different Coxsackie serotypes. However, a rising IgM titre accompanied by elevated cardiac enzymes (troponin, CK-MB) and ECG abnormalities strongly suggests Coxsackie B myocarditis. The IgG/IgM pattern is one piece of the diagnostic puzzle; the treating physician integrates clinical examination, imaging, and virologic PCR testing for a final diagnosis.
4. Is home phlebotomy safe for this specific blood test?
Yes. The specimen required is standard peripheral serum (blood), which is collected via routine venipuncture by our trained DHA-licensed phlebotomists. The sample is transported under strict temperature-controlled cold-chain conditions (2–8°C) to maintain antibody integrity. Home collection is fully insured and follows UAE infection control standards. Patients with bleeding disorders or on anticoagulation should confirm suitability with their referring physician prior to booking.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance: All patient data associated with the Coxsackie Antibodies IgG & IgM Panel is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety, patient consent, and phlebotomy protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and is licensed by the Dubai Health Authority (DHA) and the Ministry of Health and Prevention (MOHAP).
Clinical & Logistical Metadata
| Test Name | Coxsackie Antibodies IgG & IgM Panel |
| Price (AED) | 600 AED |
| Turnaround Time | Same-day report if sample received by 9 am Monday–Friday; otherwise next working day |
| Sample Type / Matrix | Serum (peripheral venous blood) — VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Enzyme-Linked Immunosorbent Assay (ELISA) — solid-phase indirect immunoassay for dual IgG/IgM detection |
| ICD-10-CM Code | B34.1, B33.22, B08.4 |
| LOINC Code | 31208-2, 31209-0 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | DNA Labs UAE — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians